Диссертация (1139537), страница 49
Текст из файла (страница 49)
Paterson // Ann. Clin. Biochem. – 1998. – Vol.35, № 2. – P. 181–200.343. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease /G.M. Reaven // Diabetes. – 1988. – Vol. 37. – P. 1595–1607.344. Relationship between psoriasis severity, clinical symptoms, quality of life andwork productivity among patients in the USA / N.J. Korman [et al.] // J. Clin.
Exp.Dermatol. – 2016. – Vol. 41, № 5. – P. 514-521.345. Resolved psoriasis lesions retain expression of a subset of disease-related genes /M. Suarez-Farinas [et al.] // J. Invest. Dermatol. – 2011. – Vol. 131. – P. 391–400.346. Role of low-level laser therapy in neurorehabilitation / J.T. Hashmi [et al.] // PMR.– 2010. – Vol. 12, Suppl. 2. – P. 292–305.347. Role of photodynamic therapy in psoriasis: a brief review / K.L.
Tandon Yasmeen[et al.] // Photodermatology. Photoimmunology. Photomedicine. – 2008. – Vol. 24,№ 5-8. – Р. 222–230.348. Rozenblit M. New biologies for psoriasis and psoriatic arthritis / M. Rozenblit, M.Lebwohl // Dermatol. Ther. – 2009. – Vol. 22, № L. – P. 56–60.349. Russo P.A. Psychiatric morbidity in psoriasis: a review / P.A. Kusso, R. Ichef, A.J.Cooper // Australas. J. Dermatol. – 2004. – Vol.
45. – P. 155–161.273350. Safety Surveillance for ustekinumab and other psoriasis treatments from thePsoriasis Longitudinal Assessment and Registry (PSOLAR) / K. Papp [et al.] // J.Drugs Dermatol. – 2015. – Vol. 14, № 7. – P. 706-714.351. Salihbegovic E.M. Psoriasis and metabolic syndrome / E.M. Salihbegovic, N.Hadzigrahic, A.J.
Cickusic // Med. Arch. – 2015. – Vol. 69, № 2. – P. 85–87.352. Sampogna F. IDI Multipurpose Psoriasis Research on Vital Experiences(IMPROVE) investigators. Living with psoriasis: prevalence of shame, anger,worry, and problems in daily activities and social life / F. Sampogna, S. Tabolli, D.Abeni // Acta Derm. Venereol. – 2012. – Vol. 92, № 3. – P. 299–303.353. Schafer P. Apremilast mechanism of action and application to psoriasis andpsoriatic arthritis.Biochem Pharmacol. 2012.
Jun15; 83(12):1583-1590. Epub 2012Jan 10.354. Schmitt J. Correlation between Dermatology Life Quality Index (DLQI) scores andWork Limitations Questionnaire (WLQ) allows the calculation of percent workproductivity loss in patients with psoriasis / J. Schmitt, D. Küster // Arch. Dermatol.Res. – 2015. – Vol. 307, № 5. – P. 451–453.355. Schneider H.J.
Obesity and risk of death / H.J. Schneider, H.U. Wittchen, H.Wallaschofski // Engl. J Med. – 2009. – Vol. 360, № 10. – P. 1043.356. Seronegative spondyloarthropathies: to lump or split? / P. Nash [et al] // Ann.Rheum. Dis. – 2005. – Suppl. II – P. 9–13.357. Setty A.R. Obesity, waist circumference, weight change and the risk of psoriasis inwomen / A.R. Setty, G.
Curhan, H.K. Choi // Arch. Intern. Med. – 2007. – Vol 167.– P. 1670–1675.Полученный358. Sex Differences in High Sensitivity C-Reactive Protein in Subjects with RiskFactors of Metabolic Syndrome / V.P. Garcia [et al.] // Arq. Bras. Cardiol. – 2016.– Vol. 106, № 3. – P. 182–187.359. Sharma N. Psychiatric morbidity in psoriasis and vitiligo: a comparative study / N.Sharma, R.V. Koranne, R.K. Singh // J. Dermatol. – 2001. – Vol. 28, № 8. – P.419–423.274360. Shenoy C. Dyslipidemia in Dermatological Disorders / C. Shenoy, M.M.
Shenoy,G.K. Rao // N. Am. J. Med. Sci. – 2015. – Vol. 7, № 10. – P. 421–428.361. Sikora-Grabka E. Metabolic disorders in patients with psoriasis / E. Sikora–Grabka, M. Adamczak, A. Wiecek // Przegl. Lek. – 2011. – Vol. 68, № 12. – P.1193–1198.362. Simultaneous measurement of multiple Thl and Th2 strum cytokines in psoriasisand correlation with disease severity / S.E. Jacob [et al.] // Mediators Inflammat. –2003. – Vol. 12, № 5. – P.
309–313.363. Singh V. Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patientsof Psoriasis with Comorbid Conditions / V. Singh // Dermatol. Res. Pract. – 2016.– 1316326.364. Sleep apnea as a comorbidity in obese psoriasis patients: a cross-sectional study.Do psoriasis characteristics and metabolic parameters play a role? / E. Papadavid[et al.] // J. Eur. Acad. Dermatol.
Venereol. – 2013. – Vol. 27. – P. 820–826.365. Sohal R.S. Соепгуте Q, oxidative stress and aging / R.S. Sohal, M.J. Forster //Mitochondrion. – 2007. – Vol. 7, Suppl. – P. S103–111.366. Spilberger C.D. Manual for the state-trait anxiety inventory / C.D. Spilberger, R.L.Corsuch, R.E. Lushene. - Palo Alto, CA : Consulting Psychologist Press, 1970.367. Steude J. Interleukin-1-stimulated secretion of interleukin-8 and growth–relatedoncogene-alpha demonstrates greatly enhanced keratinocyte growth in humanraft cultured epidermis / J. Steude, R.
Kulke, E. Christophers // J. Invest. Dermatol.– 2002. – Vol. 119 (6). – P. 1254–60.368. Strange A. A genome-wide association study identifies new psoriasis susceptibilityloci and an interaction between HLA-C and ERAP1 / A. Strange, F. Capon, C.C.Spencer // Nat. Genet. – 2010. – Vol. 42.
– P. 985–990.369. Strategies for improving the quality of care in psoriasis with the use of treatmentgoals-a report on an implementation meeting / U, Mrowietz [et al.] // J. Eur. Acad.Dermatol. Venereol. – 2011. – Vol. 25, Suppl. 3. – P. 1-13.275370.
Streptococcal throat infections and exacerbation of chronic plaque psoriasis: aprospective study / J.E. Gudjonsson [et al.] // Br. J. Dermatol. – 2003. – Vol. 149,№ 3. – P. 530-534.371. Stress, social support, emotional regulation, and exacerbation of diffuse plaquepsoriasis / A. Picardi [et al.] // Psychosomatics. – 2005. – Vol. 46, № 6. – P. 556–564.372.
Sumner A.D. Components of the metabolic syndrome differ between young andold adults in the US population / A.D. Sumner, G.L. Sardi, J.F. Reed 3-rd. // J.Clin. Hypertens (Greenwich). – 2012. – Vol. 14, № 8. – P. 502–506.373. Superoxide dismutase in psoriasis, squamous cell carcinoma and basal ceilepithelioma: an immunohistochemical study / T. Kobayashi [et al.] // Br. J.Dermatol. – 1991. – Vol.
124, № 6. – P. 555–559.374. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation ofcytokines and gene targets induced by etanercept treatment and correlation withclinical response / P. Quaglino [et al.] // Dermatology. – 2011. – Vol. 223, № 1. –P. 57–67.375. The biochemistry of programmed cell death / G. Kroemer [et al.] // The FASEB J.– 1995. – Vol.
9, № 13. – Р.1277–1287.376. The contribution of perceptions of stigmatisation to disability in patients withpsoriasis / H.L. Richards [et al.] // J. Psychosom. Res. – 2001. – Vol. 50, № 1. – P.11-15.377. The contribution of perceptions of stigmatisation to disability in patients withpsoriasis / H.L.
Richards [et al.] // J. Psychosom. Res. – 2001. – Vol. 50, № 1. – P.11–15.378. The depression, anxiety, life satisfaction and affective expression levels in psoriasispatients / H. Devrimci-Ozguven [et al.] // J. Eur. Acad. Dermatol. Venereol. – 2000.– Vol. 14, № 4. – P. 267–271.379. The effect of 670-nm low laser therapy on herpes simplex type 1 / P.J. MuñozSanchez [et al.] // Photomed. Laser Surg. – 2012. – Vol. 30, № 1. – P.
37–40.276380. The effect of acth-(4-7)-pgp peptide on lipid peroxidation in liver and activity ofserum transaminases in rats under acute and chronic immobilization stressconditions / I. Bobyntsev [et al.] // Eksp. Klin. Farmakol. – 2015. – Vol. 78, № 8.– P. 18–21.381. The lipid profile in psoriasis: A controlled study / M. Akhyani [et al.] // J.
Eur.Acad. Dermatol. Venereol. – 2007. – Vol. 21. – P. 1330–1332.382. The metabolic syndrome, its component risk factors, and progression of coronaryatherosclerosis / O. Bayturan [et al.] // Arch. Intern. Med. – 2010. – Vol. 170, № 5.– P. 478–484.383. The pathophysiological role of cytokines in psoriasis / K. Asadullah [et al.] // DrugsToday (Bare). – 1999. – Vol. 35 (12). – P.
913–924.384. The peptide semax affects the expression of genes related to the immune andvascular systems in rat brain focal ischemia: genome–wide transcriptional analysis/ E.V. Medvedeva [et al.] // BMC Genomics. – 2014. – Vol. 15. – P. 228.385. The role of HLA antigens in the etiology of psoriasis / N. Bahcetepe [et al.] // Med.Glas. (Zenica). – 2013. – Vol. 10. – P.
339–342.386. The role of the palatine tonsils in the pathogenesis and treatment of psoriasis / S.L.Sigurdardottir [et al.] // Br. J. Dermatol. – 2013. – Vol. 168, № 2. – P. 237–242.387. Transepidermal water loss, serum IgE and beta-endorphin as important andindependent biological markers for development of itch intensity in atopicdermatitis / C.H. Lee [et al.] // Br. J. Dermatol. – 2006. – Vol. 154, № 6. – P. 1100–1107.388.
Trend in the prevalence of the metabolic syndrome and its impact on cardiovasculardisease incidence: the San Antonio Heart Study / C. Lorenzo [et al.] // DiabetesCare. – 2006. – Vol. 29, № 3. – P. 25–30.389. Trigatti B.L. HDL signaling and protection against coronary artery atherosclerosisin mice / B.L. Trigatti, M. Fuller // J. Biomed. Res. – 2015. – Vol. 20. – P. 30.390.
Trivial or terrible? The psychosocial impact of psoriasis / R.G. Fried [et al.] // Int.J. Dermatol. – 1995. – Vol. 34, № 2. – P. 101–105.277391. Validity study for the stigmatization experience in atopic dermatitis and psoriaticpatients / G. Schmidt [et al.] // Acta. Derm. Venereol. – 1999.
– Vol. 79, № 6. – P.443–447.392. Victor F.L. Changing paradigms in dermatology: Tumor necrosis factor alphablockade in psoriasis and psoriatic arthritis / F.L. Victor, A.B. Gottlieb, A. Menten// Clin. Dermatol. – 2003. – Vol. 21. – P. 392–397.393. Voorhees J.J. Immunopathogenesis of psoriasis / J.J. Voorhees // Dermatology atthe millennium.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
